163 related articles for article (PubMed ID: 20696470)
1. A stimuli-responsive hydrogel for doxorubicin delivery.
Dadsetan M; Liu Z; Pumberger M; Giraldo CV; Ruesink T; Lu L; Yaszemski MJ
Biomaterials; 2010 Nov; 31(31):8051-62. PubMed ID: 20696470
[TBL] [Abstract][Full Text] [Related]
2. Controlled release of doxorubicin from pH-responsive microgels.
Dadsetan M; Taylor KE; Yong C; Bajzer Z; Lu L; Yaszemski MJ
Acta Biomater; 2013 Mar; 9(3):5438-46. PubMed ID: 23022545
[TBL] [Abstract][Full Text] [Related]
3. Examination of fabrication conditions of acrylate-based hydrogel formulations for doxorubicin release and efficacy test for hepatocellular carcinoma cell.
Bayramoglu G; Gozen D; Ersoy G; Ozalp VC; Akcali KC; Arica MY
J Biomater Sci Polym Ed; 2014; 25(7):657-78. PubMed ID: 24580096
[TBL] [Abstract][Full Text] [Related]
4. The effects of fixed electrical charge on chondrocyte behavior.
Dadsetan M; Pumberger M; Casper ME; Shogren K; Giuliani M; Ruesink T; Hefferan TE; Currier BL; Yaszemski MJ
Acta Biomater; 2011 May; 7(5):2080-90. PubMed ID: 21262395
[TBL] [Abstract][Full Text] [Related]
5. Coordinate bonding strategy for molecularly imprinted hydrogels: toward pH-responsive doxorubicin delivery.
Zhang Q; Zhang L; Wang P; Du S
J Pharm Sci; 2014 Feb; 103(2):643-51. PubMed ID: 24395706
[TBL] [Abstract][Full Text] [Related]
6. In vivo bone and soft tissue response to injectable, biodegradable oligo(poly(ethylene glycol) fumarate) hydrogels.
Shin H; Quinten Ruhé P; Mikos AG; Jansen JA
Biomaterials; 2003 Aug; 24(19):3201-11. PubMed ID: 12763447
[TBL] [Abstract][Full Text] [Related]
7. Thermosensitive Injectable Hydrogel for Simultaneous Intraperitoneal Delivery of Doxorubicin and Prevention of Peritoneal Adhesion.
Chen CH; Kuo CY; Chen SH; Mao SH; Chang CY; Shalumon KT; Chen JP
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29734717
[TBL] [Abstract][Full Text] [Related]
8. Incorporation of phosphate group modulates bone cell attachment and differentiation on oligo(polyethylene glycol) fumarate hydrogel.
Dadsetan M; Giuliani M; Wanivenhaus F; Brett Runge M; Charlesworth JE; Yaszemski MJ
Acta Biomater; 2012 Apr; 8(4):1430-9. PubMed ID: 22277774
[TBL] [Abstract][Full Text] [Related]
9. Design of a pH-sensitive magnetic composite hydrogel based on salecan graft copolymer and Fe
Hu X; Wang Y; Zhang L; Xu M; Zhang J; Dong W
Int J Biol Macromol; 2018 Feb; 107(Pt B):1811-1820. PubMed ID: 29030190
[TBL] [Abstract][Full Text] [Related]
10. Redox/pH dual stimuli-responsive biodegradable nanohydrogels with varying responses to dithiothreitol and glutathione for controlled drug release.
Pan YJ; Chen YY; Wang DR; Wei C; Guo J; Lu DR; Chu CC; Wang CC
Biomaterials; 2012 Sep; 33(27):6570-9. PubMed ID: 22704845
[TBL] [Abstract][Full Text] [Related]
11. Redox/pH dual stimuli-responsive degradable Salecan-g-SS-poly(IA-co-HEMA) hydrogel for release of doxorubicin.
Hu X; Wang Y; Zhang L; Xu M; Dong W; Zhang J
Carbohydr Polym; 2017 Jan; 155():242-251. PubMed ID: 27702509
[TBL] [Abstract][Full Text] [Related]
12. HPMA-hydrogels containing cytostatic drugs. Kinetics of the drug release and in vivo efficacy.
St'astný M; Plocová D; Etrych T; Kovár M; Ulbrich K; Ríhová B
J Control Release; 2002 May; 81(1-2):101-11. PubMed ID: 11992683
[TBL] [Abstract][Full Text] [Related]
13. Featured Article: Chemotherapeutic delivery using pH-responsive, affinity-based release.
Cyphert EL; Fu AS; von Recum HA
Exp Biol Med (Maywood); 2017 Apr; 242(7):692-699. PubMed ID: 28178856
[TBL] [Abstract][Full Text] [Related]
14. Glyoxylic Hydrazone Linkage-Based PEG Hydrogels for Covalent Entrapment and Controlled Delivery of Doxorubicin.
Sharma PK; Singh Y
Biomacromolecules; 2019 Jun; 20(6):2174-2184. PubMed ID: 31021601
[TBL] [Abstract][Full Text] [Related]
15. Redox and pH dual responsive poly(amidoamine) dendrimer-poly(ethylene glycol) conjugates for intracellular delivery of doxorubicin.
Hu W; Qiu L; Cheng L; Hu Q; Liu Y; Hu Z; Chen D; Cheng L
Acta Biomater; 2016 May; 36():241-53. PubMed ID: 26995505
[TBL] [Abstract][Full Text] [Related]
16. pH-responsive self-healing injectable hydrogel based on N-carboxyethyl chitosan for hepatocellular carcinoma therapy.
Qu J; Zhao X; Ma PX; Guo B
Acta Biomater; 2017 Aug; 58():168-180. PubMed ID: 28583902
[TBL] [Abstract][Full Text] [Related]
17. Hydrogel-PLGA delivery system prolongs 2-methoxyestradiol-mediated anti-tumor effects in osteosarcoma cells.
Maran A; Dadsetan M; Buenz CM; Shogren KL; Lu L; Yaszemski MJ
J Biomed Mater Res A; 2013 Sep; 101(9):2491-9. PubMed ID: 23355512
[TBL] [Abstract][Full Text] [Related]
18. Poly(ethylene glycol) shell-sheddable TAT-modified core cross-linked nano-micelles: TAT-enhanced cellular uptake and lysosomal pH-triggered doxorubicin release.
Zhang Y; Xiao Y; Huang Y; He Y; Xu Y; Lu W; Yu J
Colloids Surf B Biointerfaces; 2020 Apr; 188():110772. PubMed ID: 31999965
[TBL] [Abstract][Full Text] [Related]
19. Stimuli-responsive PEGylated prodrugs for targeted doxorubicin delivery.
Xu M; Qian J; Liu X; Liu T; Wang H
Mater Sci Eng C Mater Biol Appl; 2015 May; 50():341-7. PubMed ID: 25746279
[TBL] [Abstract][Full Text] [Related]
20. Carboxymethyl cellulose/graphene oxide bio-nanocomposite hydrogel beads as anticancer drug carrier agent.
Rasoulzadeh M; Namazi H
Carbohydr Polym; 2017 Jul; 168():320-326. PubMed ID: 28457456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
